DOI: http://dx.doi.org/10.18203/2349-2902.isj20203801

Unique position of a pancreatic head insulinoma during laparoscopic enucleation: case report

Abdullah M. Alshamrani, Hisham M. Ghabbani, Omar M. Alobaid, Abdullah J. AlShehri, Khalid M. Alzaraa, Haider A. Alshurafa

Abstract


Insulinomas are benign pancreatic neuroendocrine tumors that require surgical intervention as a therapeutic measure. We describe an 18-year-old male patient who presented to the emergency department with a history of syncope, blurred vision, and diaphoresis. His blood sugar level was low upon admission, and a 72-hour fasting plasma glucose test showed low serum glucose, high serum insulin, and high C-peptide. An abdominal computed tomography scan and magnetic resonant imaging revealed a solitary tumor in the pancreatic head with no sign of ductal dilatation. Laparoscopic enucleation was performed, and a histopathological examination revealed findings consistent with insulinoma. The patient’s postoperative course was uneventful, and his follow-up examination was unremarkable. In conclusion, physicians should have a high clinical suspicion index for insulinomas, especially in young patients with a history of syncope, blurred vision, and diaphoresis, in order to avoid delayed diagnosis.


Keywords


Insulinoma, Laparoscopy, Pancreatic insulinoma

Full Text:

PDF

References


Mathur A, Gorden P, Libutti SK. Insulinoma. Surg Clin North Am. 2009;89:1105-21.

Kennedy E, Brody J, Yeo C. Neoplasms of the Endocrine Pancreas. In: Mulholland MW, Lillemoe K, Doherty G, Maier R, Simeone D, Upchurch G, editors. Greenfield’s Surg Sci Princ Pract. Philadelphia, Pa. London: Lippincott Williams & Wilkins. 2010.

Davì MV, Boninsegna L, Dalle Carbonare L, Toaiari M, Capelli P, Scarpa A, et al. Presentation and outcome of pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1 syndrome. Neuroendocrinology. 2011;94:58-65.

Mulholland MW, Doherty GM. Complications in Surgery. 2nd edition. Philadelphia, Pa. London: Lippincott Williams & Wilkins; 2012.

Falconi M, Mantovani W, Crippa S, Mascetta G, Salvia R, Pederzoli P. Pancreatic insufficiency after different resections for benign tumours. Br J Surg. 2008;95:85-91.

Patel S, Narwari M, Parekh D, Shah V. Insulinoma: case report and review of diagnostic and treatment modalities. J Assoc Physicians India. 2013;61:423-6.

Tesfaye N, Seaquist ER. Neuroendocrine responses to hypoglycemia. Ann N Y Acad Sci. 2010;1212:12-28.

Bouslama K, Maghrebi H, Bedioui H, Bouslama K. L’insulinome pancréatique: approche diagnostique et modalités thérapeutiques. J Afr Hépato-Gastroentérologie. 2014;8:11-5.

Okabayashi T. Diagnosis and management of insulinoma. World J Gastroenterol. 2013;19:829.

Lou I, Inabnet WB. Chapter 18-Advances in the diagnosis and management of insulinoma. In: Shifrin AL, editor. Adv Treat Manag Surg Endocrinol. Elsevier; 2020;199-206.

Shin JJ, Gorden P, Libutti SK. Insulinoma: pathophysiology, localization and management. Future Oncol Lond Engl. 2010;6:229-37.

Taye A, Libutti SK. Diagnosis and management of insulinoma: current best practice and ongoing developments. Res. Rep. Endocr. Disord. 2015. Available at: https://www.dovepress.com/diagnosis-and-management-of-insulinoma-current-best-practice-and-ongoi-peer-reviewed-fulltext-article-RRED. Accessed on: 08 January 2020.

Jensen RT, Cadiot G, Brandi ML, de Herder WW, Kaltsas G, Komminoth P, et al. ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes. Neuroendocrinology. 2012;95:98-119.